- Telehealth Visits
- Insurance plan information
Timothy Judson, MD, MPH
He | Him | His- Telehealth Visits
- Insurance plan information
Timothy Judson, MD, MPH
He | Him | His- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Timothy Judson is an internal medicine specialist who cares for patients in the hospital and also provides acute care when patients come to the clinic for urgent but non-life-threatening issues. He serves as medical director of care delivery transformation and medical co-director of adult care transitions.
Judson's research focuses on using digital health tools to redesign and improve health care. He studies ways to give patients more virtual care options and prevent unnecessary emergency room visits and hospitalizations.
Judson earned his medical degree from the Weill Cornell Medical College. He completed a residency in internal medicine at UCSF, where he also served as chief resident. He earned his master of public health degree at Tufts University School of Medicine.
In his free time, Judson enjoys trail running, cooking, and exploring nature with his two kids.
Education & training
Board certification
- Clinical Informatics, American Board of Preventive Medicine
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, University of CA at San Francisco School of Med
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, Weill Cornell Graduate School of Medical Sciences
Clinical Trials query: q=health_gateway_id_ss%3A%28%222416%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222416%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.